Blood Flow Resistance and the Cardiovascular System {#S1}
===================================================

Flow velocity in a given tube depends on pressure and flow resistance. According to Poiseuille's Law ([@B116]), flow resistance depends on the geometry of the tube \[length (L) and radius of the tube (r)\] and the fluid's viscosity (η), and is calculated using the following formula:
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When applying Poiseuille's Law to the cardiovascular system, one must consider the radius and the length of the vessels, and the viscosity of the blood. The dimensions of the vascular system (most notably the radius, which is raised to the fourth power) play a more important role in determining vascular resistance than blood viscosity does. However, several works conducted in the past 10--15 years have shown that, in a physiological context, the parameters of this equation cannot be considered to be truly independent of each other. This is because vessels are not rigid tubes; they can change their diameters in response to various physiological stimuli. One of the most important molecules that promotes an augmentation in vascular diameter (i.e., vasodilation) is nitric oxide (NO). [@B99], [@B145], [@B80], and [@B136] showed that mild to moderate increases in hematocrit and blood viscosity did not result in a rise in vascular resistance or blood pressure, but actually caused the opposite effect. They also showed that increasing blood viscosity promoted the activation of endothelial NO-synthase through shear stress-dependent mechanisms, resulting in higher NO production, compensatory vasodilation, and decreased arterial pressure. However, evidence shows that these vascular adaptations can only occur in a functioning vascular system with a healthy endothelium. When vascular dysfunction is present, vasodilation is impaired. Therefore, a rise in blood viscosity is not accompanied by an increase in vasodilation. As a result, vascular resistance and arterial pressure increase ([@B149]; [@B127]). Although the role of blood viscosity in vascular adaptations is often ignored, these studies clearly demonstrate that vascular geometry and blood viscosity should not be considered separately when studying the regulation of vascular resistance in healthy populations or in people with cardiovascular diseases.

Blood is Not a Simple Fluid {#S2}
===========================

Whole blood is a two-phase liquid, composed of cellular elements suspended in plasma, an aqueous solution containing organic molecules, proteins, and salts ([@B13]). The cellular phase of blood includes, erythrocytes, leukocytes, and platelets. White blood cells and platelets can affect blood rheology, but under normal conditions, red blood cells (RBCs) have the biggest influence ([@B117]). Blood rheological properties are determined by the physical properties of these two phases and their relative contribution to total blood volume.

Blood is a non-Newtonian, shear thinning fluid with thixotropic and viscoelastic properties. Many cardiovascular handbooks consider blood viscosity values between 3.5 and 5.5 cP to be normal. However, blood viscosity cannot be summarized by a single value. Due to the shear thinning property of blood, which is dependent on RBC rheological properties, the viscosity of this fluid changes depending on the hemodynamic conditions. The same blood can have a viscosity value of 60 cP at a shear rate of 0.1 s^--1^, whereas the viscosity would be 5 or 6 cP at a shear rate of 200 s^--1^. This means that blood viscosity is different in the large arteries, the veins, and the microcirculation, where shear rate can vary from few s^--1^ to more than 1000 s^--1^ ([@B45]). Blood viscosity depends on several factors: hematocrit, plasma viscosity, the ability of RBCs to deform under flow, and RBC aggregation-disaggregation properties ([@B13]; [@B43]).

Effect of Hematocrit {#S2.SS1}
--------------------

Whole blood viscosity is dependent on the number (and volume) of erythrocytes in the blood, and is thus linearly related to hematocrit ([@B38]). The impact of hematocrit on blood viscosity is much higher at low shear rates (veins for instance) than at high shear rate (arteries for instance) ([@B43]). At high shear rate, it is estimated that a rise of hematocrit of one unit would cause an increase of blood viscosity of 4% (if RBC rheological properties remain the same).

Plasma Viscosity {#S2.SS2}
----------------

Plasma is a newtonian fluid, which means that its viscosity does not vary with shear rate. The viscosity of plasma is dependent on the concentration of plasma proteins, such as fibrinogen, α1-globulins, α2-globulins, β-globulins, and γ-globulins ([@B50]). Any elevation in the concentration of these proteins can cause plasma, and thus whole blood, viscosity to increase ([@B83]). Normal plasma at 37 degrees Celsius has a viscosity of around 1.2--1.3 cP, but these values may be higher in various inflammatory, metabolic, or cardiovascular diseases ([@B83]). Furthermore, increased plasma viscosity is associated with higher rates of adverse clinical events in unstable angina pectoris and stroke ([@B83]).

RBC Deformability {#S2.SS3}
-----------------

Red blood cell deformability is another important determinant of blood viscosity. RBC deformability depends on several factors, including internal (cytosolic) viscosity (mainly determined by the mean cell hemoglobin concentration), membrane viscoelasticity (which is dependent on cytoskeleton proteins and lipid bilayer properties), and the surface-area-to-volume ratio (also called cell sphericity) ([@B41]; [@B123]). At low shear rates, rigid RBCs are less likely to aggregate than deformable RBCs. Therefore, a loss of RBC deformability at very low shear rates (less than 1 s^--1^) results in a decrease in blood viscosity ([@B39]). In contrast, at shear rates above 1 s^--1^, a decrease in RBC deformability causes blood viscosity to increase ([@B39]).

Initial experiments done to analyze RBC deformability in blood flow were conducted in the 1970s and 1980s using microtubes ([@B72]) and rheoscopes ([@B69]). These studies demonstrated that, as shear stress increases, normal RBCs align with the direction of flow by deforming into an elliptical shape via a "tank tread-like" motion of the cell membrane around the cytoplasm ([@B129]; [@B72]; [@B69]). Rigid RBCs, on the other hand, cannot properly deform into an ellipse and remain perpendicular to blood flow, consequently increasing vascular resistance. In these fundamental experiments, RBCs were suspended in solutions, such as dextrose, with higher viscosities than the internal viscosity of a RBC ([@B72]; [@B69]). However, when a RBC is flowing in plasma *in vivo*, the plasma viscosity is lower than the viscosity of the erythrocyte's cytosol. This is important because recent experiments reveal that the "tank-treading" behavior of erythrocytes does not occur when RBCs are suspended in solutions with lower viscosities that are more similar to plasma viscosity *in vivo* ([@B60]). Instead, observations by [@B90] showed that RBCs display a wide variety of cell shapes for any given flow condition. For example, erythrocytes in dilute suspensions behave like rigid oblate ellipsoids at low shear rates (\<1 s^--1^). Then, as shear rates increase, the erythrocytes successively tumble, roll, and deform into stomatocytes, and eventually adopt highly deformed poly-lobed. The findings of [@B90] suggest that the pathological alterations of multiple parameters, including plasma composition, erythrocyte cytosol viscosity, and/or membrane mechanical properties could contribute to pathological blood rheology and flow. Further research should be conducted to determine how decreased RBC deformability could affect RBC shape transitions.

Red blood cell deformability is also a key determinant of blood flow in the microcirculation. RBCs are bi-concave disks with an average diameter of around 7--8 μm. Capillaries can have a diameter of less than 5 μm. Therefore, RBC must be highly deformable to pass through the narrowest vessels of the microcirculation. A 15% decrease in RBC deformability has been shown to cause a 75% increase in whole flow resistance in isolated perfused rat hind limbs ([@B15]). Moreover, when dog lungs were perfused with rigid RBC, whole pulmonary arterial pressure increased, and the main increase was localized in the microcirculation ([@B78]; [@B118]). Indeed, any decrease of RBC deformability may affect flow resistance, tissue perfusion, and oxygenation ([@B112]).

RBC Aggregation {#S2.SS4}
---------------

Red blood cell aggregation is the reversible formation of three-dimensional stacks of RBC, called "rouleaux," which takes place at low shear rates. This unique process requires low energy and is reversible under high shear rate conditions. RBC aggregation depends on both plasma and cellular factors. Initially, most research on RBC aggregation formation was focused on the effects of protein levels, polymer type, and concentration. More recent research has shown that RBC cellular properties can also modulate a cell's intrinsic tendency to aggregate (termed RBC aggregability) ([@B14]). For example, RBC surface properties, including surface charge and glycocalyx depth, also play an important role in this process. Two models have been proposed to explain RBC aggregation mechanisms ([@B100]), the depletion model and the bridging model. The depletion model suggests that RBC aggregates are formed due to osmotic pressure from surrounding plasma proteins or other macromolecules. The bridging model suggests that aggregates form due to "crossbridges," made of plasma proteins or other macromolecules ([@B119]). Fibrinogen is the most physiologically relevant macromolecule that promotes RBC aggregation ([@B119]), but other molecules, including thrombospondin and the von-Willebrand factor, also play a role ([@B103]).

The impact of RBC aggregation on blood flow, tissue perfusion and vascular resistance is complex and depends on the vascular areas where RBC aggregates are flowing. RBC aggregates usually form in low shear rate areas, such as in veins or in bifurcations. Therefore, increased RBC aggregation would cause a dramatic increase of blood viscosity in these zones. RBC aggregates disaggregate in high shear rate areas, such as in arteries and arterioles. However, it has been demonstrated that some RBC aggregates can persist in large arteries and affect flow dynamics. Increased RBC aggregation has been shown to promote RBC axial migration in these vessels, which in turn increases the cell free layer width ([@B11]). This latter phenomenon has three main consequences: (i) a decrease of apparent dynamic blood viscosity and of flow resistance, (ii) a decrease of wall shear stress, which in turn results in a lower activation of endothelial NO-synthase, lower NO production, and less vasodilation, and (iii) an increase of plasma skimming phenomena at bifurcations, which in turn lowers microcirculatory hematocrit and blood viscosity (Fharaeus and Fahraeaus--Lindqvist effects).

At the microcirculatory level, persisting RBC aggregates may increase pre-capillary resistance. Experiments performed on large glass tubes also shown that the consequences of RBC aggregation on flow resistance are dependent on the orientation of the tube (vertical vs. horizontal) ([@B42]). In horizontal tubes, elevated RBC aggregation increases RBC sedimentation, thereby increasing flow resistance. On the other hand, in vertical tubes RBC aggregation increases RBC axial migration and facilitates blood flow. For this reason, the consequences of increased RBC aggregation on blood flow are difficult to predict. However, experiments done on whole organs, such as guinea pig hearts, reported that gradually increasing RBC aggregation causes a 3-phase evolution of blood flow resistance ([@B158]). First, when RBC aggregation was increased by 50--100%, the authors observed a rise in blood flow resistance. Next, a 100--150% increase in RBC aggregation caused blood flow resistance to decrease. Finally, an increase in RBC aggregation of over 150% caused blood flow resistance to increase once again. Overall, predicting the consequences of increased RBC aggregation *in vivo* appears to be complex. However, clinical works performed to study aggregation in cardiovascular, metabolic, or inflammatory diseases consistently show that people with these diseases generally have higher RBC aggregation levels than healthy individuals, and the elevated aggregation contributes to the development of adverse disease outcomes ([@B141]; [@B16]; [@B27]; [@B87]; [@B91]; [@B113]; [@B132]).

Sickle Cell Disease, Blood Rheology and Vascular Dysfunction {#S3}
============================================================

Sickle cell disease (SCD) is the most prevalent genetic disease in the world. Sickle cell anemia (SCA) is by far the most common form of SCD, followed by hemoglobin SC disease (SC) ([@B114]). It is estimated that more than 300,000 children are born each year with a severe inherited hemoglobinopathy, over 80% of these infants are born in low-or middle-income countries, and approximately 220,000 are affected by SCA ([@B114]).

Sickle Cell Anemia as a Hemorheological Disease {#S3.SS1}
-----------------------------------------------

Sickle cell anemia is caused by a single nucleotide mutation (adenine → thymine) in exon I of the β-globin gene. This point mutation (rs334 T) leads to the production of sickle hemoglobin (HbS), due to the substitution of valine for glutamic acid at the sixth position of the β-globin chain. The hydrophobic residue of valine associates with other hydrophobic residues, which causes HbS molecules to aggregate, forming fibrous precipitates when hemoglobin is deoxygenated. This phenomenon is called "HbS polymerization," and is responsible for the characteristic shape change, termed "sickling," of RBCs. Sickle RBC are rigid, and therefore do not easily flow through the microcirculation, causing frequent vaso-occlusive episodes in affected patients. In addition, when RBCs lose their deformability, they become more fragile and prone to hemolysis, which is the root cause of chronic hemolytic anemia in SCA ([@B53]).

Although the loss of RBC deformability is a fundamental characteristic of SCA, patients exhibit varying degrees of RBC rigidity, which can differentially affect SCA disease severity and complications ([@B124]). Newborns usually have almost normal RBC deformability because they still have a high percentage of fetal hemoglobin (HbF) ([@B124]). However, when patients become older HbF is replaced by HbS, and, as a result, RBC deformability decreases ([@B124]). Hydroxyurea (HU) therapy can affect RBC deformability because HU stimulates HbF synthesis, thereby improving RBC deformability, although the deformability values still remain lower than in the healthy population ([@B93]). In individuals who are not under HU therapy, the presence or absence of alpha-thalassemia can also modulate RBC deformability ([@B122]), as the inheritance of alpha-thalassemia results in decreased production of HbS ([@B120]) and thus lower HbS polymerization.

Rigid, sickle deformed RBC can cause pre-capillary obstruction and contribute to vaso-occlusion ([@B120]). Furthermore, RBC deformability further decreases during acute vaso-occlusive events. However, patients (adults and children over 5 years of age) who have the highest RBC deformability at steady-state, and who are not under HU therapy, actually have a higher risk of developing frequent painful vaso-occlusive crises, as well as osteonecrosis ([@B89]; [@B95]; [@B122]). This paradox seems to be due to the fact that in SCA, RBC with the highest deformability are also the most adherent, which would trigger vaso-occlusion ([@B6]). On the other hand, individuals who have improved RBC deformability as a result of HU therapy do not have an elevated risk of vaso-occlusive crisis because HU inhibits RBC, platelets and WBC adhesion to the vascular wall via several mechanisms ([@B10]; [@B92]; [@B32]; [@B111]; [@B150]). RBC aggregation is usually lower in SCA patients because of low hematocrit and the inability of irreversible sickle cell to form aggregates. However, the formed RBCs aggregates are reported to be much more robust than in healthy population which could further alter blood flow and tissue perfusion at the pre and post capillary levels ([@B142]; [@B53]).

Sickle cell anemia patients with the highest degree of chronic hemolysis (i.e., those with the most severe anemia) are usually characterized by a severe and chronic reduction of RBC deformability as well as the presence of robust RBC aggregates, and seem to be more prone to develop complications such as leg ulcers, priapism and glomerulopathy ([@B9]; [@B51]; [@B88]). In contrast, patients with the highest RBC deformability tend to have less severe anemia and increased blood viscosity, which could increase the risk of developing frequent vaso-occlusive like complications ([@B105]; [@B89]; [@B33]). Surprisingly, a recent study did not show a further rise of blood viscosity during acute painful vaso-occlusive crisis ([@B91]). Instead, the authors found a decrease of RBC deformability, as a result of massive RBC sickling ([@B7]), and a rise in RBC aggregation and RBC aggregates robustness, which would probably impair blood flow into the microcirculation ([@B91]).

Vascular Function Cannot Compensate for the Hemorheological Alterations in SCA {#S3.SS2}
------------------------------------------------------------------------------

As previously discussed, recent works have demonstrated that increased blood viscosity does not systematically cause a rise in vascular resistance in healthy individuals ([@B149]; [@B127]). Instead, increasing blood viscosity can facilitate vasodilation and decrease vascular resistance through shear stress-dependent mechanisms, which increase NO production. However, when endothelial/vascular dysfunction is present, like in SCA ([@B82]; [@B2]; [@B33]), vasodilation is impaired. Therefore, a rise in blood viscosity cannot be fully compensated for, and could increase the risk of frequent vaso-occlusive crises ([@B94]; [@B33]).

Chronic hemolysis is highly implicated in the development of vascular dysfunction in SCA. Once hemoglobin is released into the plasma it autoxidizes, forming free heme, iron, and reactive oxygen species, which cause eNOS uncoupling, and decrease NO bioavailability ([@B82]). These alterations limit the relaxation of vascular smooth muscle, and contribute to the onset of vaso-occlusive crises ([@B79]). In addition, hemolysis releases the arginase contained in erythrocytes into the plasma. The free arginase hydrolyzes arginine, which is the NO precursor, to ornithine and urea, thereby exacerbating the decrease of NO bioavailability ([@B82]).

Xanthine oxidase (XO) also contributes to vascular dysfunction in SCA. [@B1] demonstrated that episodes of intrahepatic hypoxia-reoxygenation, which can occur in SCA, induce the release of plasma XO. The released XO can impair vascular function by binding to the vessel luminal cells. This creates an oxidative milieu, which results in NO scavenging via an oxygen free radical-dependent mechanism. Furthermore, [@B102] recently showed that loss of microvascular function in children with SCA was significantly associated with both nitrotyrosine and markers of systemic oxidative stress. These findings confirm the important roles oxidative stress and NO scavenging play in the development of vascular dysfunction in SCA.

Circulating extra-vesicles, such as microparticles ([@B31], [@B30]) and exosomes ([@B84]), are also thought to play a role in the development of vascular dysfunction in SCA. Indeed, [@B31] demonstrated that infusion of *in vitro*-generated RBC microparticles caused kidney vaso-occlusion in sickle cell mice. Additionally, [@B84] demonstrated that exosomes isolated from SCA patients with frequent vaso-occlusive crises decreased endothelial permeability and promoted P-selectin expression on cultured endothelial cells. The exosomes isolated from SCA patients with frequent vaso-occlusive crises also significantly increased the adhesion of monocytes to the vascular wall in mice, compared with exosomes isolated from SCA patients with a less severe phenotype. Overall, these works suggest that therapies focusing both on blood rheology and vascular function could be helpful to decrease the clinical severity of SCA patients.

Exercise and Blood Rheology in Healthy Individuals and Individuals With SCA {#S4}
===========================================================================

Blood rheology plays an important role in the regulation of tissue perfusion at rest and during exercise. For example, RBCs need to be highly deformable to easily flow through small capillaries and transport oxygen to the tissues ([@B112]). Any changes in RBC rheological properties during exercise may affect blood viscosity ([@B13]), which in turn may impact blood flow and exercise performance ([@B52]; [@B152]). Several investigators have reported significant correlations between blood fluidity and indices of physical fitness in sportsmen, such as time of endurance until exhaustion, aerobic working capacity at 170 W (W170), and maximal oxygen consumption (VO~2max~) ([@B65]; [@B19], [@B24], [@B25]).

The Effect of Acute Cycling Exercise on Blood Viscosity and Its Determinants in Healthy Individuals {#S4.SS1}
---------------------------------------------------------------------------------------------------

Most of the studies conducted in the eighties and nineties to investigate the acute effects of exercise on blood rheology focused on cycling efforts performed by moderately trained subjects ([@B21]). These studies reported that acute cycling exercise caused blood viscosity measured at high shear rate (i.e., 100--200 s^--1^) to increase by more than 15% above pre-exercise values ([@B21]; [@B46], [@B52]; [Figure 1](#F1){ref-type="fig"}). This increase in blood viscosity has been attributed to changes in plasma viscosity, hematocrit, and RBC rheological properties ([@B21]).

![Effects of different kind of exercise on blood viscosity measured at several shear rates in the same trained subject (maximal oxygen consumption, VO~2~max = 64 ml/kg/min). The maximal treadmill and cycling tests consisted in a progressive and maximal exercise conducted until VO~2~max and performed in laboratory conditions (temperature: 24°C). The 10 km running was performed outdoor (20°C) and at the highest intensity the subject could run. Indeed, the subject ran at 77% of his maximal aerobic velocity determined on the treadmill and reached a heart rate of 92% of his maximal heart rate. The subject did not drink water during each test. For the three tests, blood was sampled immediately at the end of the exercise and blood viscosity was measured with the same cone-plate viscometer within 1 h after sampling.](fphys-10-01329-g001){#F1}

Multiple studies have shown that an acute bout of maximal or submaximal cycling exercise may cause plasma viscosity to increase by 10--12%, compared to resting values ([@B61]; [@B64]; [@B23], [@B21]; [@B18]; [@B47]). This increase has been attributed to a rise in plasma protein content, such as fibrinogen, α1-globulins, α2-globulins, β-globulins, and γ-globulins during exercise ([@B108]; [@B57]; [@B147]; [@B155]).

Several studies have also shown that an acute cycling exercise can result in a 10--12% (i.e., 3--4 units) rise in hematocrit, when compared to pre-exercise values ([@B23]; [@B18]; [@B46]). The effect of elevated hematocrit on blood viscosity at high shear rates has been well described ([@B43]). A 1-unit increase in hematocrit can cause a 4% increase in blood viscosity. This rise in hematocrit has been attributed to several mechanisms such as fluid shift between intra- and extra-vascular spaces ([@B133]; [@B115]), dehydration ([@B108]; [@B138]) the release of sequestered RBCs from the spleen ([@B81]), and water trapping in muscle ([@B115]).

Acute cycling exercise can also modulate RBC deformability. Several authors have reported a decrease in RBC deformability during and immediately after exercise ([@B121]; [@B70]; [@B77]; [@B20], [@B22]; [@B110]; [@B156], [@B157]). This decrease could be a consequence of lactic acid and reactive oxygen species production that occurs during exercise ([@B52]). The accumulation of lactate ions and the decrease in pH would promote RBC dehydration through the activation of several RBC cationic channels, leading to RBC shrinkage and decreased RBC deformability ([@B146]; [@B97]; [@B135]; [@B48]). Moreover, several groups have suggested that oxidative stress could also play a role in the decreased RBC deformability through the oxidation of membrane lipid and protein components ([@B130], [@B131]; [@B52]). However, the magnitude of the change in RBC deformability that occurs during exercise seems to depend on the training status and physical fitness of the subjects. For instance, [@B130] reported that a short, progressive, maximal cycling exercise test promoted oxidative stress in both sedentary and well-trained subjects, but they only observed a decrease in RBC deformability and an increase of RBC fragility in sedentary individuals.

Very few studies have observed RBC aggregation during cycling exercise, and the results of these studies are very heterogeneous ([@B52]). [@B157] found that RBC aggregation decreased after a Wingate exercise test. In contrast, [@B64] observed a transient increase in RBC aggregation above pre-exercise values after 1 h of pedaling at a heart rate of 150 beats min^--1^. RBC aggregation then returned to baseline during the 2 h following the cycling test. [@B148] and [@B49] found no change in RBC aggregation in response to submaximal/maximal cycling exercise. The discrepancies observed are not very well understood and might be related to the (1) kind of exercise performed (short versus prolonged exercise), (2) time of measurement during exercise (i.e., immediately at the end of exercise or few minutes after), (3) time delay for measurement after sampling, and (4) procedure used for RBC aggregation measurement (adequate oxygenation and adjusted hematocrit before measurement or not).

On the whole, these changes lead to a rise in blood viscosity during acute cycling exercise. Large elevations in blood viscosity have generally been considered to be deleterious for the cardiovascular system ([@B21]; [@B52]). However, [@B55] reported a positive correlation between the magnitude of change in blood viscosity and the magnitude of change in NO end-stable products, and a negative correlation between the magnitude of change in blood viscosity and the magnitude of change in vascular resistance. These findings suggest that increasing blood viscosity during exercise could be a way to stimulate endothelium-dependent NO production through shear stress-related mechanisms. In healthy individuals, this would result in compensatory vasodilation, thereby preventing any large increases in vascular resistance.

Acute Running Exercise, Blood Viscosity and Its Determinants in Healthy Individuals {#S4.SS2}
-----------------------------------------------------------------------------------

Surprisingly, in contrast to cycling exercises, running exercises, such as a marathon or a 10-km race, do not cause a rise in blood viscosity ([@B106]; [@B143]; [Figure 1](#F1){ref-type="fig"}). The main reason is that hematocrit and plasma viscosity usually remain very stable during these kinds of efforts, despite dehydration ([@B70]; [@B106]; [@B107]). It has been hypothesized that the lack of change in hematocrit could be explained by repeated RBC foot strike hemolysis during running ([@B106]; [@B107]; [@B143]; [@B52]). However, a recent study in which highly trained subjects performed a progressive and maximal treadmill test did not observe any signs of RBC damage or eryptosis ([@B104]). However, the picture could be slightly different during ultra-running events. For instance, [@B125] reported increased hemolysis and large plasma volume expansion immediately after a 166-km long mountain ultra-endurance marathon with 9500 m of altitude gain/loss. The impact of these changes on blood rheology has not been investigated and further studies are needed to address this question.

Surprisingly, [@B104] found a slight but significant increase in RBC deformability in response to a short and maximal exercise test. Indeed, although hematocrit increased, blood viscosity remained unchanged (and tended to decrease), as has been observed in previous studies ([@B107]; [@B143]). The findings suggest that the slight increase in RBC deformability could have compensated for the rise in hematocrit observed during short running events, resulting in a lack of change in blood viscosity. The impact of ultra-run events on RBC deformability is unknown. Several other groups found a slight increase in RBC deformability during running ([@B139]) and cycling ([@B56]) exercises. Although the exact reasons for these findings are unknown, it has been suggested that increased NO production during exercise could increase RBC deformability. One of the first works to suggest that NO could affect RBC deformability was the study of [@B137], which demonstrated that intravenous infusion of L-NAME (an eNOS inhibitor) in rats caused a reduction of RBC deformability. In addition, [@B17] reported that several eNOS inhibitors also decreased RBC deformability, suggesting that basal release of NO actively maintains RBC deformability. While extracellular sources of NO may impact the deformability of RBC, several works suggest that endogenous RBC NO synthesis may also modulate RBC deformability ([@B86]). [@B139] demonstrated that an acute running exercise induced shear stress activation of RBC NOS (increased RBC NOS phosphorylation at Ser1177) via the PI3-kinase/Akt kinase pathway, leading to increased NO production by the RBC, which was critical to maintaining RBC deformability during exercise. [@B76] further extended these findings by showing that RBC NOS activation by pharmacological treatment (insulin) increased RBC NO content and improved RBC deformability through direct S-nitrosylation of cytoskeleton proteins, most likely the α- and β-spectrins. In contrast, the use of RBC NOS inhibitors \[wortmannin or L-N5-(1-Iminoethyl)-ornithin\] resulted in a decrease of RBC NOS Ser1177 phosphorylation, NO content, cytoskeleton protein S-nitrosylation, and RBC deformability.

Impact of Physiological Changes During Acute Exercise on Blood Viscosity {#S4.SS3}
------------------------------------------------------------------------

As discussed above, acute cycling exercise would lead to a rise in blood viscosity while running exercise would be characterized by a lack of change in blood viscosity compared to the pre-exercise values. Although methodological aspects could partly explain some of these differences, such as the use of different viscometers (cone-plate viscometer, couette viscometer, capillary viscometer, etc.) or the use of different shear rates (low, moderate, and high shear rate viscosity are affected by different RBC rheological parameters), the picture is probably a little bit more complex. Several physiological changes occur during exercise, which may affect blood viscosity.

To avoid large dehydration during exercise, sportsmen usually drink water or carbohydrate-rich drinks. However, most of the studies performed in the field of blood rheology have been done in laboratory conditions where water is not allowed during the various exercise tests and water loss cannot be compensated by water intake. [@B144] and [@B58] previously tested the impact of add-libitum hydration and water deprivation on blood viscosity during a prolonged submaximal exercise and a soccer game, respectively. Healthy individuals and subjects carrying sickle cell trait were included. While hydration during exercise was able to decrease blood viscosity below the pre-exercise levels in sickle cell trait carriers, blood viscosity increased similarly in healthy individuals in both the "hydration" and "water deprivation" conditions. The rate of dehydration was around 1.5--2% in these studies, which is not very severe. There is a growing interest from the runners community to participate to very prolonged race (\>100 kms), sometimes performed at high altitude. The impact of the environment and higher dehydration rate on blood viscosity are unknown and further studies are needed.

Exercise is accompanied by a rise cardiac output and blood flow leading to an increase of shear rate values in the vascular system. For instance, shear rate in the femoral artery has been reported to increase from 60 s^--1^ at rest to 200--250 s^--1^ during exercise ([@B73]). Blood is a shear-thinning fluid, meaning that its viscosity decreases when shear rate increases. [@B52] shown that 15 min of cycling exercise performed at a submaximal intensity increased blood viscosity measured at 90 s^--1^. However, when the viscosity of the blood sampled at the end of exercise was measured at 225 s^--1^ (which reflects the shear rate reached during exercise), the mean value was almost identical to the viscosity of the blood sampled before exercise and measured at 90 s^--1^. Indeed, the effects of hemoconcentration, increased plasma viscosity, decreased RBC deformability and increased RBC aggregation on blood viscosity during exercise could be counterbalanced by the effects of increasing shear rate ([@B52]). However, the slight remaining changes in blood viscosity observed during exercise were still correlated with the magnitude of changes in NO-end products concentration, suggesting that blood viscosity plays a role in promoting NO production during exercise ([@B52]).

Core temperature rises during exercise and it is well known that blood viscosity also depends on temperature ([@B12]). A recent elegant study shown that when the changes in temperature occurring during exercise are took into account in the measurements of blood viscosity, there is no difference between the pre- and post-exercise values ([@B28]). The slight physiological hyperthermia was shown to increase RBC deformability, which compensated the rise in hematocrit and resulted in a lack of change in blood viscosity. The authors estimated that the combined effects of increasing shear rate and hyperthermia during exercise could decrease blood viscosity by 31% below the pre-exercise levels, in spite of the exercise induced hemoconcentration ([@B28]). These findings clearly show that studies in the field of exercise hemorheology should consider the effects of various physiological factors for better interpretation about the role of blood viscosity in the cardiovascular adaptations and physical fitness.

Long Term Effects of Exercise on Blood Rheology in Healthy Individuals {#S4.SS4}
----------------------------------------------------------------------

Chronic exercise (endurance or resistance exercise) usually decreases blood viscosity ([@B21]; [@B126]; [@B85]). One reason for this change is that plasma volume increases few hours or several days after a single bout of exercise ([@B68]; [@B21]), resulting in an "autohemodilution" ([@B62]; [@B63]). Repeated exercise bouts on consecutive days leads to a chronic "autohemodilution" resulting in a low baseline hematocrit -- low baseline viscosity pattern ([@B62]; [@B21]; [@B85]). The magnitude of plasma volume expansion ranges from 9 to 25%, corresponding to an additional 300 to 700 ml of plasma. It has been shown that the larger the reduction in plasma volume during exercise, the greater the subsequent plasma volume expansion ([@B68]). The amount of water ingested during and after exercise, as well several fluid-regulating hormones (aldosterone, vasopressin and the atrial natriuretic factor) and the level of plasma proteins, influence the degree of the plasma volume expansion after exercise. Plasma volume expansion is responsible for the decrease in plasma viscosity that contributes to the decrease in blood viscosity ([@B62]).

Exercise training also induces RBC rheological adaptations ([@B26]; [@B85]). [@B62] reported increased RBC deformability in athletes compared to sedentary subjects, a finding later confirmed by [@B134]. A 3-month longitudinal study of initially untrained healthy volunteers who performed regular training also showed a decrease of blood viscosity and a rise of RBC deformability ([@B62]). Few studies have been conducted to determine why RBC deformability improves in healthy individuals after chronic exercise. However, [@B134] and [@B140] found a higher proportion of young deformable RBCs in athletes than in untrained subjects. The hemorheological benefits induced by regular exercise are suspected to contribute to the improvements in cardiovascular health that are induced by training programs in patients with cardiovascular disorders ([@B128]).

Acute and Chronic Effects of Exercise in SCA {#S4.SS5}
--------------------------------------------

The metabolic changes occurring during exercise may promote HbS polymerization, RBC sickling, oxidative stress and inflammation. For this reason, physicians have generally been reluctant to promote physical activity for individuals with SCA ([@B44]; [@B151]; [@B40]; [@B98]). However, since regular physical activity has been shown to provide health benefits in various chronic diseases, several groups have begun to study the effects of acute and chronic exercise in individuals and mice with SCA.

Sickle cell anemia patients have decreased aerobic physical fitness compared to the general population ([@B54]). This is probably due to a combination of several factors, including chronic anemia, reduced muscle mass and strength, abnormal cardiac function, gas exchange abnormalities, mechanical ventilation limitations and peripheral vascular impairment ([@B29]; [@B59]; [@B96]; [@B4]; [@B101]). A recent study reported negative associations between the oxygen uptake efficiency slope (an index of aerobic physical fitness) and hematocrit, RBC deformability, and RBC aggregate strength in adults with SCA ([@B34]). These biological parameters were also associated with the ability of recover from a short submaximal exercise ([@B34]). In another study, [@B154] showed that high levels of anemia, low fetal hemoglobin levels, and low RBC deformability were independent predictors of a low 6-min walking test performance.

Blood rheological abnormalities play a key role in the pathophysiology of SCA. For this reason, several works have investigated the effects of acute exercise on various biological parameters to determine what kind of exercise could be considered completely safe for individuals with SCA. In a study performed in Ivory Coast, 17 patients with SCA performed a 20 min moderate exercise (45 Watts) with blood sampling before and at the end of exercise ([@B5]; [@B66]). Despite an increase in the percentages of dense RBC at the end of the effort, blood viscosity and soluble forms of P- and E-selectin remained unchanged compared to the pre-exercise level ([@B5]; [@B66]). Slight increases of the plasma soluble forms of VCAM-1 and ICAM-1 were noted at the end of the exercise in SCA patients, suggesting slight endothelial activation ([@B66]). On the other hand, another study by [@B96] reported higher concentrations of soluble VCAM-1 in the plasma of SCA patients at rest compared to a control group, but progressive and maximal exercise tests did not induce any further rise of VCAM-1. An additional study by [@B153] evaluated blood rheological parameters in subjects with SCA following a short (10--12 min) progressive submaximal cycling exercise, conducted until the first ventilatory threshold was reached. The exercise caused no changes in hematocrit, white blood cell count, blood viscosity, RBC deformability, or RBC aggregation. Furthermore, the strength of RBC aggregates decreased 2 and 3 days after the exercise. This delayed effect of exercise on RBC aggregate strength could be beneficial from a clinical point of view since this parameter is associated with risk of acute chest syndrome ([@B89]), and is increased during vaso-occlusive crises ([@B91]). [@B75] recently confirmed that a short progressive and submaximal cycling exercise had no deleterious effect on RBC deformability and showed that this kind of effort does not exacerbate hemolysis. Finally, [@B8] previously reported that the repetition of 30 min of moderate exercise for three consecutive days increased plasma NO concentrations in subjects with SCA. This could be viewed as a positive effect since NO bioavailability is reduced in SCA ([@B82]). It is important to note that none of these studies reported any clinical complications immediately or several days after the exercise ([@B8]; [@B5]; [@B153]; [@B66]; [@B75]). Overall, the results of these studies suggest that mild-to-moderate intensity exercise is probably safe in SCA, but longer or high-intensity exercise should be avoided, or recommended only on a case-by-case basis ([@B98]). Still, some patients may experience moderate to severe hemoglobin desaturation, even during low-intensity or submaximal exercises, like the 6-min walking test ([@B154]). Hemoglobin desaturation can promote RBC sickling in conditions of prolonged hypoxemic stress. Therefore, SCA patients should always be screened for hemoglobin desaturation during exercise tests to identify whether the person is at risk of experiencing exercise-induced hypoxemia during submaximal efforts.

The accumulating evidence showing that acute exercise could be safe for SCA patients prompted several groups to test the effects of regular exercise in mice and humans with SCA. Studies conducted in sickle SAD mice showed that 8 weeks of voluntary wheel running decreased blood viscosity ([@B67]), limited systemic oxidative stress ([@B35]), and decreased pulmonary endothelial activation in response to an hypoxic-reoxygenation stimulus ([@B3]). An additional study conducted by [@B36] evaluated the effects of 8 weeks of aerobic training (1 h/day, 5 days/week) in a more severe mice model of SCA (Townes mice). The chronic exercise decreased several markers of systemic inflammation, including white blood cell count, plasma Th1/Th2 cytokine ratio, and Interleukin-1β level, and reduced the occurrence of splenomegaly. Furthermore, two other studies have also shown that endurance training improved muscle function in Townes SCA mice ([@B37]; [@B74]).

Presently, only a few studies have been conducted to evaluate chronic exercise in people with SCA. [@B109] recently reported that 90% of children with SCA participate in physical education and 48% participate in sports. These findings illustrate that children with SCA do moderate to vigorous intensity physical activity for short durations. The same research group also prescribed three home exercise sessions per week, for 12 weeks, to 13 children with SCA. Results showed that 77% of subjects completed 89% of the prescribed sessions without any exercise-related adverse events. These results indicate that regular moderate exercise is safe and feasible in children with SCA. In an additional study by [@B71], adults with SCA performed 45 min of exercise three times a week for 8 weeks. No adverse events were reported in the study period, confirming that regular physical activity can be safe for people with SCA. Moreover, the SCA subjects' power outputs measured at 4 mmol/L blood lactate significantly increased after the 8 weeks training period, indicating improved physical fitness. Currently, no human studies have been conducted to determine whether chronic exercise can modulate the biological parameters (i.e., blood rheology, hematology, inflammation, oxidative stress) that cause the various acute complications experienced by people with SCA. However, the current evidence that exists suggests that moderate-intensity endurance-exercise training could potentially be used as a beneficial therapeutic strategy for patients with SCA ([@B71]).

Conclusion {#S5}
==========

In conclusion, whole blood viscosity is a physiological parameter that should be considered when studying vascular resistance in healthy populations or in patients affected by various diseases. Plasma viscosity, hematocrit, RBC deformability, and RBC aggregation are all factors that modulate blood viscosity. Alterations in any of these factors can modify blood flow resistance in the vasculature and alter tissue perfusion. In healthy individuals, the vascular system can adapt to elevations in blood viscosity because increased shear stress results in endothelium-dependent NO production. However, in individuals with vascular dysfunction, the vessels are not able to effectively vasodilate. Therefore, elevated blood viscosity can increase vascular resistance.

Tissue perfusion plays a key role during exercise and exercise can modulate blood viscosity and RBC rheology. The effects of acute exercise in healthy individuals are dependent on exercise modality, intensity, duration and physical fitness of the subjects. Most of the studies have found that acute cycling exercise increases blood viscosity by decreasing RBC deformability and increasing hematocrit and plasma viscosity ([Figure 2](#F2){ref-type="fig"}). In contrast, acute running exercise is suggested to not cause any change in blood viscosity because of unaltered hematocrit ([Figure 2](#F2){ref-type="fig"}). Furthermore, chronic exercise has been shown to decrease blood viscosity by increasing RBC deformability and decreasing hematocrit because of chronic auto-hemodilution ([Figure 2](#F2){ref-type="fig"}).

![Acute **(A)** and chronic **(B)** effects of exercise on blood rheology (blood viscosity, plasma viscosity, hematocrit, red blood cell deformability, and aggregation) in healthy individuals and patients with sickle cell anemia., ↑, ↓; =, no change; ?, unknown.](fphys-10-01329-g002){#F2}

Sickle cell anemia is a hereditary disease that causes pathological changes in blood rheology that ultimately contribute to the development of vascular dysfunction and disease complications. Several studies have shown that light to moderate intensity acute exercise is well-tolerated in individuals with SCA ([Figure 2](#F2){ref-type="fig"}). Additionally, chronic exercise has been shown to cause positive hemorheological adaptations that could play a role in the positive benefits that result from training programs in patients with various cardiovascular disorders ([Figure 2](#F2){ref-type="fig"}). Therefore, additional studies should be carried out to determine whether chronic exercise could improve blood rheological profiles in individuals with SCA, and decrease the severity of disease complications.
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